Heliyon
Volume 9, Issue 4, April 2023, e15032
Research articleComputational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus
Under a Creative Commons license
open access
Keywords
Protein engineering
Coronavirus Disease 2019
Computational antibody design
Monoclonal antibody therapeutics
Diagnostic
Cited by (0)
- 1
Equal contribution.
© 2023 The Authors. Published by Elsevier Ltd.